Total trials
46
Active
29
Phase 3
0
Total enrollment
8,867
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Avascular Necrosis10
- Congenital Hip Dysplasia7
- Traumatic Arthritis7
- Arthritis6
- Total Hip Arthroplasty4
- Osteoarthritis4
- Primary Osteoarthritis4
- Secondary Osteoarthritis4
Frequently asked questions about Medacta International SA
- How many clinical trials does Medacta International SA have on ClinicalTrials.gov?
- Medacta International SA is listed as the lead sponsor on 46 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medacta International SA's trials are in Phase 3?
- 0 of Medacta International SA's trials are in Phase 3.
- What therapeutic areas does Medacta International SA focus on?
- Medacta International SA's most-studied conditions on ClinicalTrials.gov are Avascular Necrosis, Congenital Hip Dysplasia, Traumatic Arthritis, Arthritis, Total Hip Arthroplasty.